We are live on
!
Find out more
EPGL
Evelyn Partners Group Ltd Portfolio holdings
AUM
$46.9B
This Fund
S&P 500
This Quarter
Est. Return
-2.15%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$46.9B
AUM Growth
–
Cap. Flow
+$5.86B
Cap. Flow
% of AUM
12.5%
Top 10 Holdings %
Top 10 Hldgs %
93.6%
Holding
551
New
551
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$421M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$409M |
| 3 |
Amazon
AMZN
|
+$395M |
| 4 |
Microsoft
MSFT
|
+$378M |
| 5 |
NVIDIA
NVDA
|
+$261M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 89.62% |
| 2 | Technology | 2.91% |
| 3 | Financials | 2.09% |
| 4 | Communication Services | 1.32% |
| 5 | Consumer Discretionary | 1.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Martin Marietta Materials
MLM
$33B
| $2.74M | 0.01% |
+4,744
| New | +$2.81M |
|
127
EOG Resources
EOG
$70.7B
| $2.73M | 0.01% |
+21,009
| New | +$2.86M |
|
|
AXON
128
Axon Enterprise
AXON
$46.4B
| $2.62M | 0.01% |
+4,668
| New | +$1.95M |
|
129
Palantir
PLTR
$413B
| $2.59M | 0.01% |
+22,194
| New | +$3.03M |
|
130
SAP
SAP
$238B
| $2.57M | 0.01% |
+16,677
| New | +$2.84M |
|
131
AbbVie
ABBV
$435B
| $2.47M | 0.01% |
+9,801
| New | +$2.11M |
|
132
IBM
IBM
$224B
| $2.46M | 0.01% |
+8,736
| New | +$2.2M |
|
133
RTX Corp
RTX
$301B
| $2.45M | 0.01% |
+12,928
| New | +$2.37M |
|
134
Texas Instruments
TXN
$261B
| $2.43M | 0.01% |
+8,136
| New | +$2.26M |
|
|
MRSH
135
Marsh
MRSH
$91.5B
| $2.42M | 0.01% |
+14,517
| New | +$2.43M |
|
136
International Paper
IP
$22B
| $2.36M | 0.01% |
+61,986
| New | +$2.12M |
|
137
Spotify
SPOT
$100B
| $2.32M | 0.01% |
+5,055
| New | +$2.41M |
|
138
Blackrock
BLK
$176B
| $2.23M | ﹤0.01% |
+2,318
| New | +$2.4M |
|
139
abrdn Physical Silver Shares ETF
SIVR
$4.42B
| $2.13M | ﹤0.01% |
+37,875
| New | +$2.64M |
|
140
Diageo
DEO
$53.6B
| $2.12M | ﹤0.01% |
+26,313
| New | +$2.12M |
|
141
Morgan Stanley
MS
$340B
| $2.1M | ﹤0.01% |
+10,063
| New | +$1.99M |
|
142
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
| $2.07M | ﹤0.01% |
+9,718
| New | +$1.99M |
|
143
Rio Tinto
RIO
$164B
| $2.05M | ﹤0.01% |
+21,600
| New | +$2.19M |
|
144
UBS Group
UBS
$176B
| $2.03M | ﹤0.01% |
+40,992
| New | +$1.87M |
|
145
WisdomTree Japan Hedged Equity Fund
DXJ
$7.42B
| $1.99M | ﹤0.01% |
+11,478
| New | +$1.93M |
|
146
Merck
MRK
$318B
| $1.91M | ﹤0.01% |
+14,867
| New | +$1.74M |
|
147
GE Vernova
GEV
$264B
| $1.89M | ﹤0.01% |
+1,610
| New | +$1.64M |
|
148
Coinbase
COIN
$40.5B
| $1.8M | ﹤0.01% |
+12,307
| New | +$2.22M |
|
|
B
149
Barrick Mining
B
$73.2B
| $1.79M | ﹤0.01% |
+48,770
| New | +$2M |
|
150
Graham Holdings Company
GHC
$5.02B
| $1.78M | ﹤0.01% |
+1,563
| New | +$1.76M |
|
Similar funds
TI
LP
RIM
Evelyn Partners Group Ltd's Q2 2026 Portfolio in Review
Q2 2026 is the first quarter with a 13F filing on record for Evelyn Partners Group Ltd, which disclosed 551 positions worth $46.9B. Its ten largest holdings account for 94% of the portfolio.
Its largest position is AstraZeneca: 2,237,205 shares worth $41.5B.
By sector, the portfolio is most concentrated in Healthcare at 90% of assets, followed by Technology and Financials.
- Evelyn Partners Group Ltd's largest Q2 2026 buy was AstraZeneca: 2,237,205 shares worth $41.5B.
- Evelyn Partners Group Ltd's ten largest holdings make up 94% of its $46.9B portfolio in Q2 2026.
- Evelyn Partners Group Ltd disclosed 551 positions in Q2 2026, its first 13F filing on record.
Based on Evelyn Partners Group Ltd's 13F filing for Q2 2026, filed 7 Aug 2026.